Makary

Health

FDA Commissioner to Review Abortion Pill

Sarah Wagner -
FDA Commissioner Marty Makary confirmed that he will review the safety of the abortion drug mifepristone after a study revealed troubling adverse health outcomes exceeding the risks reported on its label.

Latest news

- Advertisement -spot_img
This material may not be published, broadcast, rewritten, or redistributed. ©2023 American Faith News Media. All rights reserved.